Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review

被引:2
|
作者
Ding, Hanyi [1 ,2 ]
Liu, Na [3 ,5 ]
Wang, Yan [1 ,3 ]
Adam, Sofia Abdulkadir [3 ]
Jin, Jie [1 ,3 ,4 ]
Feng, Weiying [2 ]
Sun, Jie [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Shaoxing Peoples Hosp, Dept Hematol, Shaoxing, Zhejiang, Peoples R China
[3] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
[5] Weifang Med Univ, Affiliated Hosp, Sch Clin Med, Dept Oncol, Weifang, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Pseudouridine; RNA modification; Pseudouridine synthase; Cancer diagnosis; Cancer treatment; MESSENGER-RNA; URINARY PSEUDOURIDINE; SERUM PSEUDOURIDINE; MODIFIED NUCLEOTIDES; TRANSLATION CONTROL; BIOCHEMICAL MARKER; DKC1; NUCLEOSIDES; DIAGNOSIS; EXPRESSION;
D O I
10.1186/s12967-024-05687-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundPseudouridine (Psi), a C5-glycoside isomer of uridine, stands as one of the most prevalent RNA modifications in all RNA types. Distinguishing from the C-N bond linking uridine to ribose, the link between Psi and ribose is a C-C bond, endowing Psi modified RNA distinct properties and functions in various biological processes. The conversion of uridine to Psi is governed by pseudouridine synthases (PUSs). RNA pseudouridylation is implicated in cancer biology and therapeutics.ObjectivesIn this review, we will summarize the methods for detecting Psi, the process of Psi generation, the impact of Psi modification on RNA metabolism and gene expression, the roles of dysregulated Psi and pseudouridine synthases in cancers, and the underlying mechanism.MethodsWe conducted a comprehensive search of PubMed from its inception through February 2024. The search terms included "pseudouridine"; "pseudouridine synthase"; "PUS"; "dyskerin"; "cancer"; "tumor"; "carcinoma"; "malignancy"; "tumorigenesis"; "biomarker"; "prognosis" and "therapy". We included studies published in peer-reviewed journals that focused on Psi detection, specific mechanisms involving Psi and PUSs, and prognosis in cancer patients with high Psi expression. We excluded studies lacking sufficient methodological details or appropriate controls.Results Psi has been recognized as a significant biomarker in cancer diagnosis and prognosis. Abnormal Psi modifications mediated by various PUSs result in dysregulated RNA metabolism and impaired RNA function, promoting the development of various cancers. Overexpression of PUSs is common in cancer cells and predicts poor prognosis. PUSs inhibition arrests cell proliferation and enhances apoptosis in cancer cells, suggesting PUS-targeting cancer therapy may be a potential strategy in cancer treatment.DiscussionHigh Psi levels in serum, urine, and saliva may suggest cancer, but do not specify the type, requiring additional lab markers and imaging for accurate diagnosis. Standardized detection methods are also crucial for reliable results. PUSs are linked to cancer, but more researches are needed to understand their mechanisms in different cancers. Anticancer treatments targeting PUSs are still under developed.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The Role of Alternative RNA Splicing in the Regulation ofhTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics
    Slusher, Aaron L.
    Kim, Jeongjin J. J.
    Ludlow, Andrew T.
    CANCERS, 2020, 12 (06) : 1 - 16
  • [32] Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
    Pfeifer, Blaine A.
    Beitelshees, Marie
    Hill, Andrew
    Bassett, Justin
    Jones, Charles H.
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2023, 9 (01)
  • [33] Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
    Blaine A. Pfeifer
    Marie Beitelshees
    Andrew Hill
    Justin Bassett
    Charles H. Jones
    npj Systems Biology and Applications, 9
  • [34] Circularized RNA as novel therapeutics in cancer
    Pena-Paladines, Jessica Jazmin
    Wong, Chi Hin
    Chen, Yangchao
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 156
  • [35] RNA Therapeutics for the Treatment of Brain Cancer
    Hicks, Martin Joseph
    Gawargi, Flobater
    MOLECULAR THERAPY, 2021, 29 (04) : 213 - 214
  • [36] RNA-chromatin interactions: Biology, mechanism, disease and therapeutics
    Mathiyalagan, Prabhu
    Martelotto, Luciano G.
    Ounzain, Samir
    El-Osta, Assam
    Uchida, Shizuka
    FRONTIERS IN GENETICS, 2023, 13
  • [37] RNA therapeutics for the Treatment of Brain Cancer
    Hicks, Martin
    Gawargi, Flobater
    Fink, Ryan
    Sine, Laura
    Hintlemann, Thomas
    FASEB JOURNAL, 2021, 35
  • [38] Extracellular Vesicles: Biology and Potentials in Cancer Therapeutics
    Cho, William C. S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [39] Prostate Cancer: Biology, Genetics and the New Therapeutics
    Lee, John A.
    LANCET ONCOLOGY, 2001, 2 (04): : 248 - 248
  • [40] The chemistry and biology of vanadium compounds in cancer therapeutics
    Kioseoglou, Efrosini
    Petanidis, Sawas
    Gabriel, Catherine
    Salifoglou, Athanasios
    COORDINATION CHEMISTRY REVIEWS, 2015, 301 : 87 - 105